Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions
- PMID: 26184442
- DOI: 10.1016/j.neuropsychologia.2015.07.012
Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions
Abstract
When choosing between two options, sufficient accumulation of information is required to favor one of the options over the other, before a decision is finally reached. To establish the effect of dopaminergic medication on the rate of accumulation of information, decision thresholds and speed-accuracy trade-offs, we tested 14 patients with Parkinson's disease (PD) on and off dopaminergic medication and 14 age-matched healthy controls on two versions of the moving-dots task. One version manipulated the level of task difficulty and hence effort required for decision-making and the other the urgency, requiring decision-making under speed vs. accuracy instructions. The drift diffusion model was fitted to the behavioral data. As expected, the reaction time data revealed an effect of task difficulty, such that the easier the perceptual decision-making task was, the faster the participants responded. PD patients not only made significantly more errors compared to healthy controls, but interestingly they also made significantly more errors ON than OFF medication. The drift diffusion model indicated that PD patients had lower drift rates when tested ON compared to OFF medication, indicating that dopamine levels influenced the quality of information derived from sensory information. On the speed-accuracy task, dopaminergic medication did not directly influence reaction times or error rates. PD patients OFF medication had slower RTs and made more errors with speed than accuracy instructions compared to the controls, whereas such differences were not observed ON medication. PD patients had lower drift rates and higher response thresholds than the healthy controls both with speed and accuracy instructions and ON and OFF medication. For the patients, only non-decision time was higher OFF than ON medication and higher with accuracy than speed instructions. The present results demonstrate that when task difficulty is manipulated, dopaminergic medication impairs perceptual decision-making and renders it more errorful in PD relative to when patients are tested OFF medication. In contrast, for the speed/accuracy task, being ON medication improved performance by eliminating the significantly higher errors and slower RTs observed for patients OFF medication compared to the HC group. There was no evidence of dopaminergic medication inducing impulsive decisions when patients were acting under speed pressure. For the speed-accuracy instructions, the sole effect of dopaminergic medication was on non-decision time, which suggests that medication primarily affected processes tightly coupled with the motor symptoms of PD. Interestingly, the current results suggest opposite effects of dopaminergic medication on the levels of difficulty and speed-accuracy versions of the moving dots task, possibly reflecting the differential effect of dopamine on modulating drift rate (levels of difficulty task) and non-decision time (speed-accuracy task) in the process of perceptual decision making.
Keywords: Dopaminergic medication; Effort-based decision-making; Impulsivity; Parkinson's disease; Response threshold; Speed–accuracy trade-off.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Perceptual decision-making in patients with Parkinson's disease.J Psychopharmacol. 2014 Dec;28(12):1149-54. doi: 10.1177/0269881114548437. Epub 2014 Sep 18. J Psychopharmacol. 2014. PMID: 25237123
-
Subthalamic nucleus deep brain stimulation induces impulsive action when patients with Parkinson's disease act under speed pressure.Exp Brain Res. 2016 Jul;234(7):1837-1848. doi: 10.1007/s00221-016-4577-9. Epub 2016 Feb 18. Exp Brain Res. 2016. PMID: 26892884 Free PMC article.
-
Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.Exp Neurol. 2014 Apr;254:70-7. doi: 10.1016/j.expneurol.2014.01.005. Epub 2014 Jan 18. Exp Neurol. 2014. PMID: 24444545 Clinical Trial.
-
The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.Neuropsychologia. 2016 Oct;91:163-172. doi: 10.1016/j.neuropsychologia.2016.07.032. Epub 2016 Jul 27. Neuropsychologia. 2016. PMID: 27475264 Review.
-
Sequential Sampling Models in Cognitive Neuroscience: Advantages, Applications, and Extensions.Annu Rev Psychol. 2016;67:641-66. doi: 10.1146/annurev-psych-122414-033645. Epub 2015 Sep 17. Annu Rev Psychol. 2016. PMID: 26393872 Free PMC article. Review.
Cited by
-
Sub-second Dopamine and Serotonin Signaling in Human Striatum during Perceptual Decision-Making.Neuron. 2020 Dec 9;108(5):999-1010.e6. doi: 10.1016/j.neuron.2020.09.015. Epub 2020 Oct 12. Neuron. 2020. PMID: 33049201 Free PMC article.
-
In Parkinson's disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses.Exp Brain Res. 2016 Apr;234(4):1133-43. doi: 10.1007/s00221-015-4531-2. Epub 2016 Jan 12. Exp Brain Res. 2016. PMID: 26758720 Free PMC article.
-
Dopamine Increases Accuracy and Lengthens Deliberation Time in Explicit Motor Skill Learning.eNeuro. 2024 Jan 18;11(1):ENEURO.0360-23.2023. doi: 10.1523/ENEURO.0360-23.2023. Print 2024 Jan. eNeuro. 2024. PMID: 38238069 Free PMC article.
-
Distinct mechanisms mediate speed-accuracy adjustments in cortico-subthalamic networks.Elife. 2017 Jan 31;6:e21481. doi: 10.7554/eLife.21481. Elife. 2017. PMID: 28137358 Free PMC article.
-
Ropinirole, a dopamine agonist with high D3 affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adults.Neuropharmacology. 2020 Nov 15;179:108278. doi: 10.1016/j.neuropharm.2020.108278. Epub 2020 Aug 19. Neuropharmacology. 2020. PMID: 32827517 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
